Latest Market Strategy News

Compumedics Limited has reported a robust half-year performance, with revenue climbing 32% to $31 million and a return to profitability, driven by strong MEG system sales and SaaS growth.

Locksley Resources has initiated diamond drilling at its Desert Antimony Mine in California, aiming to expand known high-grade mineralisation and support US critical minerals supply chains.

Genesis Energy has reported a record first-half normalised EBITDAF of NZ$307 million, underpinned by strong hydro inflows and portfolio flexibility, while announcing a $400 million equity raise to accelerate its renewable growth strategy.

Terragen Holdings reports a 23% reduction in half-year net loss amid strategic shifts and completes a $7 million equity raise to accelerate global commercialisation of its biological agricultural products.

Knosys Limited reported a 4.6% revenue increase to $5.07 million for the half-year ending December 2025, driven by stronger licence and project fees. However, the company’s net loss widened significantly to $1.53 million, reflecting heavy investment in its next-generation Libero X library management system.

XRF Scientific has reported a record first half for December 2025, with revenue and profits rising on the back of strong mining demand and international expansion.

Netwealth Group Limited has reported a robust first half of FY26, with record funds under administration and a significant increase in dividends, underpinned by strong inflows and strategic technology investments.

Australian Bond Exchange Holdings has completed a $982,071 private placement, attracting new international and domestic investors to support its growth strategy.

Kinatico Ltd reports robust H1 FY26 results, driven by a 49.5% surge in SaaS revenue and the launch of its AI-powered Kinatico Compliance platform, significantly broadening its addressable market.

Treasury Wine Estates reported a statutory loss driven by a significant US asset impairment but showed underlying growth in key markets. The company suspends its interim dividend and targets $100 million in annual cost savings through its TWE Ascent program.

AVITA Medical reported an 11% increase in sales revenue for 2025, driven by deeper market penetration and new product launches, while reducing its net loss by 21%. The company secured a $60 million senior secured credit facility but flagged substantial doubt about its ability to continue as a going concern.

WAM Leaders Limited has delivered strong portfolio gains and increased its fully franked interim dividend, reflecting robust operating profits and strategic market positioning.